KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Medpace Holdings (MEDP) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $503.1 million.

  • Medpace Holdings' Cost of Revenue rose 4043.35% to $503.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.8 billion, marking a year-over-year increase of 2181.15%. This contributed to the annual value of $1.8 billion for FY2025, which is 2181.15% up from last year.
  • Latest data reveals that Medpace Holdings reported Cost of Revenue of $503.1 million as of Q4 2025, which was up 4043.35% from $463.0 million recorded in Q3 2025.
  • Medpace Holdings' Cost of Revenue's 5-year high stood at $503.1 million during Q4 2025, with a 5-year trough of $181.5 million in Q1 2021.
  • For the 5-year period, Medpace Holdings' Cost of Revenue averaged around $321.3 million, with its median value being $346.2 million (2023).
  • In the last 5 years, Medpace Holdings' Cost of Revenue crashed by 91.9% in 2024 and then skyrocketed by 4043.35% in 2025.
  • Quarter analysis of 5 years shows Medpace Holdings' Cost of Revenue stood at $220.6 million in 2021, then grew by 26.2% to $278.4 million in 2022, then increased by 29.9% to $361.6 million in 2023, then fell by 0.92% to $358.3 million in 2024, then soared by 40.43% to $503.1 million in 2025.
  • Its last three reported values are $503.1 million in Q4 2025, $463.0 million for Q3 2025, and $423.3 million during Q2 2025.